XML 36 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements Of Operations (USD $)
In Thousands, except Per Share data, unless otherwise specified
 3 Months Ended 265 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Mar. 31, 2013
Revenue     $ 3,166
Operating expenses:      
Research and development 26,398 24,156 1,493,971
General and administrative 10,039 9,777 435,743
In-process research and development costs     19,726
Goodwill impairment     151,428
Total operating expenses 36,437 33,933 2,100,868
Loss from operations (36,437) (33,933) (2,097,702)
Other income (expense) 23 1,382 (2,244)
Interest expense on note payable to related party (1,689) (3,048) (40,514)
Interest expense on senior convertible notes (2,863) (2,575) (42,796)
Interest income 1 1 36,997
Loss before benefit for income taxes (40,965) (38,173) (2,146,259)
Income tax benefit     (382)
Net loss (40,965) (38,173) (2,145,877)
Deemed dividend related to beneficial conversion feature of convertible preferred stock     (22,260)
Accretion on redeemable preferred stock     (952)
Net loss applicable to common stockholders $ (40,965) $ (38,173) $ (2,169,089)
Net loss per share applicable to common stockholders - basic and diluted $ (0.15) $ (0.27)  
Shares used to compute basic and diluted net loss per share applicable to common stockholders 280,058 143,154